TY - JOUR
T1 - Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides
AU - James Mason, A.
AU - Moussaoui, Wardi
AU - Abdelrahman, Tamer
AU - Boukhari, Alyae
AU - Bertani, Philippe
AU - Marquette, Arnaud
AU - Shooshtarizaheh, Peiman
AU - Moulay, Gilles
AU - Boehm, Nelly
AU - Guerold, Bernard
AU - Sawers, Ruairidh J.H.
AU - Kichler, Antoine
AU - Metz-Boutigue, Marie Hélène
AU - Candolfi, Ermanno
AU - Prévost, Gilles
AU - Bechinger, Burkhard
PY - 2009/1/2
Y1 - 2009/1/2
N2 - Designed histidine-rich amphipathic cationic peptides, such as LAH4, have enhanced membrane disruption and antibiotic properties when the peptide adopts an alignment parallel to the membrane surface. Although this was previously achieved by lowering the pH, here we have designed a new generation of histi-dine-rich peptides that adopt a surface alignment at neutral pH. In vitro, this new generation of peptides are powerful antibiotics in terms of the concentrations required for antibiotic activity; the spectrum of target bacteria, fungi, and parasites; and the speed with which they kill. Further modifications to the peptides, including the addition of more hydrophobic residues at the N terminus, the inclusion of a helix-breaking proline residue or using D-amino acids as building blocks, modulated the biophysical properties of the peptides and led to substantial changes in toxicity to human and parasite cells but had only a minimal effect on the antibacterial and antifungal activity. Using a range of biophysical methods, in particular solid-state NMR, we show that the peptides are highly efficient at disrupting the anionic lipid component of model membranes. However, we also show that effective pore formation in such model membranes may be related to, but is not essential for, high antimicrobial activity by cationic amphipathic helical pep-tides. The information in this study comprises a new layer of detail in the understanding of the action of cationic helical antimicrobial peptides and shows that rational design is capable of producing potentially therapeutic membrane active peptides with properties tailored to their function.
AB - Designed histidine-rich amphipathic cationic peptides, such as LAH4, have enhanced membrane disruption and antibiotic properties when the peptide adopts an alignment parallel to the membrane surface. Although this was previously achieved by lowering the pH, here we have designed a new generation of histi-dine-rich peptides that adopt a surface alignment at neutral pH. In vitro, this new generation of peptides are powerful antibiotics in terms of the concentrations required for antibiotic activity; the spectrum of target bacteria, fungi, and parasites; and the speed with which they kill. Further modifications to the peptides, including the addition of more hydrophobic residues at the N terminus, the inclusion of a helix-breaking proline residue or using D-amino acids as building blocks, modulated the biophysical properties of the peptides and led to substantial changes in toxicity to human and parasite cells but had only a minimal effect on the antibacterial and antifungal activity. Using a range of biophysical methods, in particular solid-state NMR, we show that the peptides are highly efficient at disrupting the anionic lipid component of model membranes. However, we also show that effective pore formation in such model membranes may be related to, but is not essential for, high antimicrobial activity by cationic amphipathic helical pep-tides. The information in this study comprises a new layer of detail in the understanding of the action of cationic helical antimicrobial peptides and shows that rational design is capable of producing potentially therapeutic membrane active peptides with properties tailored to their function.
UR - http://www.scopus.com/inward/record.url?scp=58649107151&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58649107151&partnerID=8YFLogxK
U2 - 10.1074/jbc.M806201200
DO - 10.1074/jbc.M806201200
M3 - Article
C2 - 18984589
AN - SCOPUS:58649107151
SN - 0021-9258
VL - 284
SP - 119
EP - 133
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 1
ER -